Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 31, 2025 05:24 ET | Source: Research and Markets

Keratoconjunctivitis Sicca (Dry Eye) Global Clinical Trials Market Review 2025 | Gain Strategic Insights for a Competitive Advantage

Dublin, July 31, 2025 (GLOBE NEWSWIRE) -- The "Keratoconjunctivitis Sicca (Dry Eye) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The...
July 28, 2025 09:46 ET | Source: Research and Markets

Dry Eye Disease Treatment Market Insights, Competitive Landscape, and Forecast Report 2024-2032 | Artificial Tears Dominate the Market, Offering Immediate Symptom Relief

Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "Dry Eye Disease Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to ResearchAndMarkets.com's offering. ...
June 23, 2025 06:14 ET | Source: Research and Markets

Acute Ocular Pain Market Research 2025-2035: Screen Time and Digital Strain Surge Demand, Regional Players and Emerging Markets Propel Growth

Dublin, June 23, 2025 (GLOBE NEWSWIRE) -- The "Acute Ocular Pain Market - A Global and Regional Analysis: Focus on Indication and Region - Analysis and Forecast, 2025-2035" report has been added to ...
January 03, 2025 06:51 ET | Source: Research and Markets

Dry Eye Products Market Opportunities and Strategies to 2033: Strategic Partnerships and Collaborations Among Major Players, Next-Generation Therapeutic Solutions for Keratoconjunctivitis Sicca

Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Dry Eye Products Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's offering. The global dry eye products...
December 04, 2024 22:58 ET | Source: Cambium Bio Limited

Cambium Bio Successfully Closes A$3.0M Financing Round

Cambium Bio Successfully Closes A$3.0M Financing Round
October 30, 2024 07:00 ET | Source: OKYO Pharma LTD

OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference

LONDON and NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic...
September 10, 2024 07:00 ET | Source: OKYO Pharma LTD

OKYO Pharma Announces Chairman Acquires Shares

LONDON and NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
September 05, 2024 07:00 ET | Source: OKYO Pharma LTD

OKYO Pharma Announces Chairman Acquires Shares

LONDON and NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
August 27, 2024 07:00 ET | Source: OKYO Pharma LTD

OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease

LONDON and NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
August 15, 2024 12:13 ET | Source: OKYO Pharma LTD

OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

LONDON and NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...